July 21, 2022
1 min read

US CDC endorses Novavax jab for adults

The recommendation came on Tuesday following a meeting of the CDC Advisory Committee on Immunization Practices…reports Asian Lite News

The US Centers for Disease Control and Prevention (CDC) has endorsed recommendation that Novavax’s Covid-19 vaccine be used as another primary series option for adults ages 18 years and older.

The recommendation came on Tuesday following a meeting of the CDC Advisory Committee on Immunization Practices, Xinhua news agency reported.

The Novavax vaccine will be available as two-dose primary series for adults, three weeks apart.

It is the fourth Covid-19 vaccine available in the US, and it uses a different type of vaccine technology than the other three approved vaccines.

“Novavax’s Covid-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of Covid-19 vaccine technology for adults,” said the CDC in a statement.

Last week, the US Food and Drug Administration issued an emergency use authorisation for the Novavax Covid-19 vaccine in individuals 18 years of age and older.

ALSO READ: Moscow registers 5 cases of Covid-19 subvariant ‘Centaurus’

Previous Story

NCPA curating a cultural extravaganza in Mumbai

Next Story

Manushi joins team ‘Tehran’

Latest from -Top News

One Million Gazans Face Starvation

UNRWA: Hunger is spreading fast in Gaza. Women and girls are forced to adopt increasingly dangerous survival strategies like venturing out in search of food and water at the extreme risk of

South Africa hosts Africa Water Summit

The conference, convened by South Africa as part of its G20 presidency and jointly organised with the African Union (AU), the AU Development Agency, and the African Union-Africa Water Investment Program (AU-AIP)
Go toTop

Don't Miss

India, US Pact on Quantum, AI Promises Breakthroughs

The minister recalled PM Modi’s recent visit to the US

Smaller rate hikes likely in December: Fed chair

Fed officials have ramped up their rhetoric in recent weeks